0001485003-17-000029.txt : 20170405
0001485003-17-000029.hdr.sgml : 20170405
20170405161618
ACCESSION NUMBER: 0001485003-17-000029
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170403
FILED AS OF DATE: 20170405
DATE AS OF CHANGE: 20170405
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001485003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262025616
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-444-8550
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DeCillis Arthur
CENTRAL INDEX KEY: 0001685148
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 17742758
MAIL ADDRESS:
STREET 1: C/O ELEVEN BIOTHERAPEUTICS
STREET 2: 215 1ST ST. #400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
wf-form4_149142336243033.xml
FORM 4
X0306
4
2017-04-03
0
0001485003
Eleven Biotherapeutics, Inc.
EBIO
0001685148
DeCillis Arthur
C/O ELEVEN BIOTHERAPEUTICS, INC.
245 FIRST STREET, SUITE 1800
CAMBRIDGE
MA
02142
0
1
0
0
Chief Medical Officer
Employee Stock Option (Right to Buy)
2.28
2017-04-03
4
A
0
19246
0
A
2027-04-02
Common Stock
19246.0
19246
D
50% of the shares subject to such option shall vest on grant date with the remaining 50% of shares underlying the option to vest on the first anniversary of the grant date.
/s/ Arthur P. DeCillis, M.D.
2017-04-05